In 1972, SPRI was founded as the Social Psychiatry Research Institute, a network of clinical sites focusing on antidepressant and anti-anxiety drug research. Today, we continue to support the biopharmaceutical industry as a multi-therapeutic contract research organization with strategic operations in the United States and Eastern Europe.
Over the past 40 years, we’ve earned a reputation for our hands-on approach, regulatory expertise and international solutions. Besides being some of the most talented clinical research professionals in the industry, the majority of SPRI’s staff also comes from a medical background — equipping our teams with the insight necessary to effectively manage even the most complex therapeutic research.
Our Therapeutic Specialities
At SPRI, we understand the obstacles that biopharmaceutical companies face when designing and implementing clinical trials. Let our highly qualified professionals minimize your risk and your timelines, balance your costs and provide submission-ready data — creating a more efficient, more effective approach to clinical research.
SPRI’s clinical expertise includes:
- Oncology – SPRI understands the complexities of oncology clinical trials, successfully navigating regulatory requirements, rapid patient recruitment and more.
- Infectious disease – SPRI has extensive experience managing global infectious disease trials for numerous indications, including HIV, HPV, HCV and HBV.
- CNS – Our CNS team includes experts on a diverse spectrum of psychiatric and neurological disorders, including Schizophrenia, Bipolar, GAD and Multiple Sclerosis.
- Endocrinology – SPRI stays abreast of the continually changing regulatory guidance related to endocrine/metabolic research in order to successfully design and execute phase I – IV trials in diabetes and growth hormones.
Additional areas of expertise include hepatic disease, rheumatology, pulmonology, women’s health and dermatology.
SPRI: International Clinical Trial Performance Experts
From initial feasibility studies and site selection to regulatory management, biostatistics, pharmacovigilance and more, trust SPRI with your next clinical trial. Since 1972, we’ve been the partner biopharmaceutical companies trust for quality, efficiency and local expertise — no matter the size or complexity of the trial.
With strategic offices in the United States (New York and North Carolina), Ukraine, Russia, Georgia and Belarus and strategic partnerships in Western Europe and Australasia, SPRI can easily navigate the challenges of international clinical trials. Contact us today to learn more about our oncology, hepatology, infectious disease, endocrinology and CNS expertise.